Abstract
BackgroundThere is often a lack of safety and efficacy data in the paediatric population at the time of drug approval. Legislative efforts have promoted clinical pharmacology research in this underserved...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have